Evidence map›Paper›PMID 19416806›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2009

The tumor suppressor WTX shuttles to the nucleus and modulates WT1 activity.

Miguel N Rivera, Woo Jae Kim, Julie Wells, Amanda Stone, Alexa Burger, Erik J Coffman, Jianmin Zhang, Daniel A Haber

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Epigenetic regulation and anti-tumorigenic effects of SH2-containing protein tyrosine phosphatase 1 (SHP1) in human gastric cancer cells.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Miguel N RiveraMassachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 20129, USA.
Woo Jae Kim
Julie Wells
Amanda Stone
Alexa Burger
Erik J Coffman
Jianmin Zhang
Daniel A Haber
Harvard University · USMassachusetts General Hospital · US

Funding

Treating the P13-Kinase/AKTP50CA101942 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Wanling Xie · 2003 to 2026
$53.4M
MOLECULAR IMMUNOLOGY AND TUMOR BIOLOGYT32CA009216 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI David Michael Langenau · 1985 to 2026
$10.6M
Functional Properties of the Wilms' Tumor Gene WT1R37CA058596 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI HABER, DANIEL A. · 2003 to 2011
$3.9M
Functional Characterization of WTX in Renal DevelopmentK08DK080175 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RIVERA, MIGUEL NICOLAS · 2007 to 2011
$687k
NCI NIH HHS P01CA101942NCI NIH HHS P50 CA101942NCI NIH HHS R37 CA058596NCI NIH HHS R37CA058596NCI NIH HHS T32 CA009216NCI NIH HHS T32CA009216NIDDK NIH HHS K08 DK080175NIDDK NIH HHS K08DK080175
6 · The paper itself

Abstract

WTX encodes a tumor suppressor gene inactivated in Wilms tumor and recently implicated in WNT signaling through enhancement of cytoplasmic beta-catenin (CTNNB1) degradation. Here, we report that WTX translocates to the nucleus, a property that is modified by an endogenous splicing variant and is modulated by a nuclear export inhibitor. WTX is present in distinct subnuclear structures and co-localizes with the paraspeckle marker p54NRB/NONO, suggesting a role in transcriptional regulation. Notably, WTX binds WT1, another Wilms tumor suppressor and stem cell marker that encodes a zinc-finger transcription factor, and enhances WT1-mediated transcription of Amphiregulin, an endogenous target gene. Together, these observations suggest a role for WTX in nuclear pathways implicated in the transcriptional regulation of cellular differentiation programs.

Indexed as

Active Transport, Cell NucleusAdaptor Proteins, Signal TransducingAmphiregulinCell LineEGF Family of ProteinsGene Expression RegulationGlycoproteinsHumansIntercellular Signaling Peptides and ProteinsProtein BindingProtein IsoformsTranscription FactorsTranscription, GeneticTransfectionTumor Suppressor ProteinsWT1 ProteinsAdaptor Proteins, Signal TransducingAMER1 protein, humanAmphiregulinAREG protein, humanEGF Family of ProteinsGlycoproteinsIntercellular Signaling Peptides and ProteinsProtein IsoformsTranscription FactorsTumor Suppressor ProteinsWT1 Proteins

Identifiers

PMID19416806
PMCPMC2677091
OpenAlexW2114491018

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.